Skip to main content
Erschienen in: Cardiovascular Toxicology 3/2010

01.09.2010

T Lymphocyte Regulation of Lysyl Oxidase in Diet-Induced Cardiac Fibrosis

verfasst von: Sherma Zibadi, Randy Vazquez, Douglas F. Larson, Ronald R. Watson

Erschienen in: Cardiovascular Toxicology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Left ventricular diastolic dysfunction is an important predictor of prognosis and mortality of heart failure. Increased left ventricular stiffness can be associated with excessive myocardial fibrosis and increased cross-linked collagen by the enzyme lysyl oxidase (LOX). These cardiac extracellular matrix (ECM) remodeling processes are affected by T-lymphocyte function and phenotype. We sought to examine the role of T lymphocytes in myocardial LOX regulation in diet-induced fibrotic hearts. Female SCID mice, devoid of functional T lymphocytes, and wild-type (WT) C57BL/6 were treated with a high-fat high-simple carbohydrate (HFHSC) diet for 12 months. HFHSC-fed WT mice demonstrated a significant increase in the catalytic activity of myocardial LOX compared with respective controls. These changes coincided with a marked increase in ECM collagen cross-linking and impaired diastolic filling pattern. However, induction of LOX was minimal in the SCID mice compared with the WT group. Correspondingly fibrillar cross-linked collagen concentrations and diastolic dysfunction were less prominent in the SCID mice compared with the WT group. Our results suggest a role for T lymphocytes in this dietary induction of diastolic dysfunction through modulation of LOX-dependent collagen maturation.
Literatur
1.
Zurück zum Zitat Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England Journal of Medicine, 355, 251–259.CrossRefPubMed Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England Journal of Medicine, 355, 251–259.CrossRefPubMed
2.
Zurück zum Zitat Kass, D. A., Bronzwaer, J. G. F., & Paulus, W. J. (2004). What mechanisms underlie diastolic dysfunction in heart failure? Circulation Research, 94, 1533–1542.CrossRefPubMed Kass, D. A., Bronzwaer, J. G. F., & Paulus, W. J. (2004). What mechanisms underlie diastolic dysfunction in heart failure? Circulation Research, 94, 1533–1542.CrossRefPubMed
3.
Zurück zum Zitat Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004). Diastolic heart failure—Abnormalities in active relaxation and passive stiffness of the left ventricle. The New England Journal of Medicine, 350, 1953–1959.CrossRefPubMed Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004). Diastolic heart failure—Abnormalities in active relaxation and passive stiffness of the left ventricle. The New England Journal of Medicine, 350, 1953–1959.CrossRefPubMed
4.
Zurück zum Zitat Badenhorst, D., Maseko, M., Tsotetsi, O. J., Naidoo, A., Brooksbank, R., Norton, G. R., et al. (2003). Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovascular Research, 57, 632–641.CrossRefPubMed Badenhorst, D., Maseko, M., Tsotetsi, O. J., Naidoo, A., Brooksbank, R., Norton, G. R., et al. (2003). Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovascular Research, 57, 632–641.CrossRefPubMed
5.
Zurück zum Zitat Smith-Mungo, L. I., & Kagan, H. M. (1998). Lysyl oxidase: Properties, regulation and multiple functions in biology. Matrix Biology, 16, 387–398.CrossRefPubMed Smith-Mungo, L. I., & Kagan, H. M. (1998). Lysyl oxidase: Properties, regulation and multiple functions in biology. Matrix Biology, 16, 387–398.CrossRefPubMed
6.
Zurück zum Zitat Yndestad, A., Ueland, T., Oie, E., Florholmen, G., Halvorsen, B., Attramadal, H., et al. (2004). Elevated levels of activin a in heart failure—Potential role in myocardial remodeling. Circulation, 109, 1379–1385.CrossRefPubMed Yndestad, A., Ueland, T., Oie, E., Florholmen, G., Halvorsen, B., Attramadal, H., et al. (2004). Elevated levels of activin a in heart failure—Potential role in myocardial remodeling. Circulation, 109, 1379–1385.CrossRefPubMed
7.
Zurück zum Zitat Yu, Q. L., Watson, R. R., Marchalonis, J. J., & Larson, D. F. (2005). A role for T lymphocytes in mediating cardiac diastolic function. American journal of physiology Heart and circulatory physiology, 289, H643–H651.CrossRefPubMed Yu, Q. L., Watson, R. R., Marchalonis, J. J., & Larson, D. F. (2005). A role for T lymphocytes in mediating cardiac diastolic function. American journal of physiology Heart and circulatory physiology, 289, H643–H651.CrossRefPubMed
8.
Zurück zum Zitat Yu, Q. L., Horak, K., & Larson, D. F. (2006). Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension, 48, 98–104.CrossRefPubMed Yu, Q. L., Horak, K., & Larson, D. F. (2006). Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension, 48, 98–104.CrossRefPubMed
9.
Zurück zum Zitat Zibadi, S., Yu, Q., Rohdewald, P. J., Larson, D. F., & Watson, R. R. (2007). Impact of Pycnogenol (R) on cardiac extracellular matrix remodeling induced by L-NAME administration to old mice. Cardiovascular Toxicology, 7, 10–18.CrossRefPubMed Zibadi, S., Yu, Q., Rohdewald, P. J., Larson, D. F., & Watson, R. R. (2007). Impact of Pycnogenol (R) on cardiac extracellular matrix remodeling induced by L-NAME administration to old mice. Cardiovascular Toxicology, 7, 10–18.CrossRefPubMed
10.
Zurück zum Zitat Yang, B., Larson, D. F., Beischel, J., Kelley, R., Shi, J., & Watson, R. R. (2001). Validation of conductance catheter system for quantification of murine pressure-volume loops. International journal of surgical investigation, 14, 341–355. Yang, B., Larson, D. F., Beischel, J., Kelley, R., Shi, J., & Watson, R. R. (2001). Validation of conductance catheter system for quantification of murine pressure-volume loops. International journal of surgical investigation, 14, 341–355.
11.
Zurück zum Zitat Palamakumbura, A. H., & Trackman, P. C. (2002). A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Analytical Biochemistry, 300, 245–251.CrossRefPubMed Palamakumbura, A. H., & Trackman, P. C. (2002). A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Analytical Biochemistry, 300, 245–251.CrossRefPubMed
12.
Zurück zum Zitat Zibadi, S., Vazquez, R., Moore, D., Larson, D. F., & Watson, R. R. (2009). Myocardial lysyl oxidase regulation of cardiac remodeling in a murine model of diet-induced metabolic syndrome. American journal of physiology Heart and circulatory physiology, 297, H976–H982.CrossRefPubMed Zibadi, S., Vazquez, R., Moore, D., Larson, D. F., & Watson, R. R. (2009). Myocardial lysyl oxidase regulation of cardiac remodeling in a murine model of diet-induced metabolic syndrome. American journal of physiology Heart and circulatory physiology, 297, H976–H982.CrossRefPubMed
13.
Zurück zum Zitat Smith-Mungo, L. I., & Kagan, H. M. (1998). Lysyl oxidase: Properties, regulation and multiple functions in biology. Matrix Biology, 16, 387–398.CrossRefPubMed Smith-Mungo, L. I., & Kagan, H. M. (1998). Lysyl oxidase: Properties, regulation and multiple functions in biology. Matrix Biology, 16, 387–398.CrossRefPubMed
14.
Zurück zum Zitat Lopez, B., Querejeta, R., Gonzalez, A., Beaumont, J., Larman, M., & Diez, J. (2009). Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. Hypertension, 53, U236–U253.CrossRef Lopez, B., Querejeta, R., Gonzalez, A., Beaumont, J., Larman, M., & Diez, J. (2009). Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. Hypertension, 53, U236–U253.CrossRef
15.
Zurück zum Zitat Kellar, R. S., Shepherd, B. R., Larson, D. F., Naughton, G. K., & Williams, S. K. (2005). Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. Tissue engineering, 11, 1678–1687.CrossRefPubMed Kellar, R. S., Shepherd, B. R., Larson, D. F., Naughton, G. K., & Williams, S. K. (2005). Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. Tissue engineering, 11, 1678–1687.CrossRefPubMed
16.
Zurück zum Zitat Song, Y. L., Ford, J. W., Gordon, D., & Shanley, C. J. (2000). Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 982–988.PubMed Song, Y. L., Ford, J. W., Gordon, D., & Shanley, C. J. (2000). Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 982–988.PubMed
17.
Zurück zum Zitat Tan, R. S. P., Taniguchi, T., & Harada, H. (1996). Identification of the lysyl oxidase gene as a target of the antioncogene transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Research, 56, 2417–2421.PubMed Tan, R. S. P., Taniguchi, T., & Harada, H. (1996). Identification of the lysyl oxidase gene as a target of the antioncogene transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Research, 56, 2417–2421.PubMed
18.
Zurück zum Zitat Shanley, C. J., GharaeeKermani, M., Sarkar, R., Welling, T. H., Kriegel, A., Ford, J. W., et al. (1997). Transforming growth factor-beta(1) increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. Journal Vascular Surgery, 25, 446–452.CrossRef Shanley, C. J., GharaeeKermani, M., Sarkar, R., Welling, T. H., Kriegel, A., Ford, J. W., et al. (1997). Transforming growth factor-beta(1) increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. Journal Vascular Surgery, 25, 446–452.CrossRef
19.
Zurück zum Zitat Rodriguez, C., Alcudia, J. F., Martinez-Gonzalez, J., Raposo, B., Navarro, M. A., & Badimon, L. (2008). Lysyl oxidase (LOX) down-regulation by TNF alpha: A new mechanism underlying TNF alpha-induced endothelial dysfunction. Atherosclerosis, 196, 558–564.CrossRefPubMed Rodriguez, C., Alcudia, J. F., Martinez-Gonzalez, J., Raposo, B., Navarro, M. A., & Badimon, L. (2008). Lysyl oxidase (LOX) down-regulation by TNF alpha: A new mechanism underlying TNF alpha-induced endothelial dysfunction. Atherosclerosis, 196, 558–564.CrossRefPubMed
20.
Zurück zum Zitat Hofnagel, O., Luechtenborg, B., Stolle, K., Lorkowski, S., Eschert, H., Plenz, G., et al. (2004). Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1789–1795.CrossRefPubMed Hofnagel, O., Luechtenborg, B., Stolle, K., Lorkowski, S., Eschert, H., Plenz, G., et al. (2004). Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 1789–1795.CrossRefPubMed
21.
Zurück zum Zitat Yu, Q. L., & Larson, D. F. (2007). Toll-like receptor induced il-12 and il-18 mediates cardiac ECM remodeling mediated by lysyl oxidase. Journal of Cardiac Failure, 13, 98.CrossRef Yu, Q. L., & Larson, D. F. (2007). Toll-like receptor induced il-12 and il-18 mediates cardiac ECM remodeling mediated by lysyl oxidase. Journal of Cardiac Failure, 13, 98.CrossRef
22.
Zurück zum Zitat Garrigue-Antar, L., Hartigan, N., & Kadler, K. E. (2002). Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein. Journal Biological Chemistry, 277, 43327–43334.CrossRef Garrigue-Antar, L., Hartigan, N., & Kadler, K. E. (2002). Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein. Journal Biological Chemistry, 277, 43327–43334.CrossRef
23.
Zurück zum Zitat Bock, O., Hoftmann, J., Theophile, K., Hussein, K., Wiese, B., Schlue, J., et al. (2008). Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. American Journal of Pathology, 172, 951–960.CrossRefPubMed Bock, O., Hoftmann, J., Theophile, K., Hussein, K., Wiese, B., Schlue, J., et al. (2008). Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. American Journal of Pathology, 172, 951–960.CrossRefPubMed
24.
Zurück zum Zitat Li, Y. Y., McTiernan, C. F., & Feldman, A. M. (2000). Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovascular Research, 46, 214–224.CrossRefPubMed Li, Y. Y., McTiernan, C. F., & Feldman, A. M. (2000). Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovascular Research, 46, 214–224.CrossRefPubMed
25.
Zurück zum Zitat Messerli, F. H. (2004). TIMPs, MMPs and cardiovascular disease. European Heart Journal, 25, 1475–1476.CrossRefPubMed Messerli, F. H. (2004). TIMPs, MMPs and cardiovascular disease. European Heart Journal, 25, 1475–1476.CrossRefPubMed
26.
Zurück zum Zitat Brown, R. D., Jones, G. M., Laird, R. E., Hudson, P., & Long, C. S. (2007). Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochemical and Biophysical Research Communications, 362, 200–205.CrossRefPubMed Brown, R. D., Jones, G. M., Laird, R. E., Hudson, P., & Long, C. S. (2007). Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochemical and Biophysical Research Communications, 362, 200–205.CrossRefPubMed
27.
Zurück zum Zitat Siwik, D. A., Chang, D. L. F., & Colucci, W. S. (2000). Interleukin-1 beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circulation Research, 86, 1259–1265.PubMed Siwik, D. A., Chang, D. L. F., & Colucci, W. S. (2000). Interleukin-1 beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circulation Research, 86, 1259–1265.PubMed
Metadaten
Titel
T Lymphocyte Regulation of Lysyl Oxidase in Diet-Induced Cardiac Fibrosis
verfasst von
Sherma Zibadi
Randy Vazquez
Douglas F. Larson
Ronald R. Watson
Publikationsdatum
01.09.2010
Verlag
Humana Press Inc
Erschienen in
Cardiovascular Toxicology / Ausgabe 3/2010
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-010-9078-7

Weitere Artikel der Ausgabe 3/2010

Cardiovascular Toxicology 3/2010 Zur Ausgabe